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BACKGROUND
Nipah virus is a highly virulent zoonotic pathogen that can be transmitted be-
tween humans. Understanding the dynamics of person-to-person transmission is 
key to designing effective interventions.
METHODS
We used data from all Nipah virus cases identified during outbreak investigations 
in Bangladesh from April 2001 through April 2014 to investigate case-patient 
characteristics associated with onward transmission and factors associated with 
the risk of infection among patient contacts.
RESULTS
Of 248 Nipah virus cases identified, 82 were caused by person-to-person trans-
mission, corresponding to a reproduction number (i.e., the average number of 
secondary cases per case patient) of 0.33 (95% confidence interval [CI], 0.19 to 
0.59). The predicted reproduction number increased with the case patient’s age 
and was highest among patients 45 years of age or older who had difficulty 
breathing (1.1; 95% CI, 0.4 to 3.2). Case patients who did not have difficulty 
breathing infected 0.05 times as many contacts (95% CI, 0.01 to 0.3) as other 
case patients did. Serologic testing of 1863 asymptomatic contacts revealed no 
infections. Spouses of case patients were more often infected (8 of 56 [14%]) 
than other close family members (7 of 547 [1.3%]) or other contacts (18 of 1996 
[0.9%]). The risk of infection increased with increased duration of exposure of 
the contacts (adjusted odds ratio for exposure of >48 hours vs. ≤1 hour, 13; 95% 
CI, 2.6 to 62) and with exposure to body fluids (adjusted odds ratio, 4.3; 95% CI, 
1.6 to 11).
CONCLUSIONS
Increasing age and respiratory symptoms were indicators of infectivity of Nipah 
virus. Interventions to control person-to-person transmission should aim to re-
duce exposure to body fluids. (Funded by the National Institutes of Health and 
others.)
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Tr ansmission of Nipah Virus in Bangladesh
Nipah virus is a batborne paramyxo-virus that is found throughout South Asia and Southeast Asia. Bangladesh is 
currently the only country regularly reporting 
human cases, including person-to-person trans-
mission.1 With a case fatality rate greater than 
70% and no available treatment or vaccines, 
Nipah virus was identified by the World Health 
Organization as an emerging infectious disease 
posing a high risk of causing an important epi-
demic.1-3 Although previous Nipah virus out-
breaks have been small,1 larger, self-sustaining 
epidemics may occur if the virus becomes more 
transmissible. Effective control measures against 
Nipah virus require an understanding of person-
to-person transmission.
Our current understanding of Nipah virus 
person-to-person transmission comes from stud-
ies that described transmission events in single 
outbreaks4-7 — for example, the father of a patient 
becoming ill after providing care for his son.5 Ad-
ditional insight was gained from biologic data, 
such as Nipah virus isolates from patients’ 
throat and oral swabs8-11 and detection of Nipah 
virus RNA on hospital surfaces.5,10 Such reports 
were useful for generating hypotheses about 
Nipah virus transmission, but they lacked the 
power to test and validate these hypotheses and 
evaluate their relative importance.
Luby et al.1 analyzed 23 Nipah virus spillovers 
(i.e., introductions from the bat reservoir into 
the human population) reported in Bangladesh 
from 2001 through 2007 and concluded that 
case patients with respiratory symptoms and 
those who died were more likely than others to 
transmit Nipah virus. However, the study had a 
small sample size and lacked systematic surveil-
lance and data about contacts and asymptomatic 
infections. More than 10 years later, the surveil-
lance of Nipah virus in Bangladesh has improved 
substantially (systematic investigation of Nipah 
virus cases and their contacts has been imple-
mented since 2007) and the number of investi-
gated Nipah virus spillover events has more than 
tripled, providing the opportunity to reassess 
what we know about Nipah virus transmission.
We present an assessment of Nipah virus 
transmission that is based on 14 years of case 
data and 8 years of extensive contact investiga-
tions from Bangladesh. All 248 cases of Nipah 
virus represented in our analysis have been re-
ported previously,1,2,4-7,10-19 but we have now ana-
lyzed these cases together with information on 
case contacts to gain new insights into drivers 
of Nipah virus transmission. These cases repre-
sent 40% of all Nipah virus cases (248 of 628 
cases) reported globally.20-23
Me thods
Identification of Case Patients
We analyzed data on all laboratory-confirmed 
and probable Nipah virus cases identified in 
Bangladesh from April 2001 through April 2014 
by hospital-based surveillance (implemented since 
2007) and outbreak investigations. A patient with 
confirmed Nipah virus infection was defined as 
a person with detectable IgM antibodies against 
Nipah virus24 (or IgG24 for retrospectively identi-
fied outbreaks), and a patient with probable 
Nipah virus infection was defined as a person 
with an epidemiologic link to a confirmed case 
patient who died before specimens for testing 
could be collected. Case detection and data col-
lection procedures, which were stable over time, 
have been described previously5,14,16,17 and are 
summarized in the Supplementary Appendix, 
available with the full text of this article at 
NEJM.org. A person with Nipah virus was clas-
sified as a secondary case patient if symptom 
onset occurred 5 to 15 days (the assumed incu-
bation period window) after contact with a con-
firmed or probable case patient (the infector).
Tracing Case Contacts
Between 2007 and 2014, we investigated contacts 
of confirmed and probable case patients; a con-
tact was defined as a person who had physical 
contact or in-person verbal communication with 
a patient 0 to 15 days (the assumed maximum 
infectious period) after illness onset. Contacts 
were asked about demographic characteristics 
and their relationship and exposure to the case 
patient. Proxy respondents were identified for 
contacts who were unable to answer for them-
selves (e.g., children or severely ill or deceased 
contacts). To assess the occurrence of asymp-
tomatic infections, during the period from Janu-
ary 2009 through April 2014 contacts without 
signs of illness were tested for Nipah virus IgG 
more than 6 weeks after they were exposed to 
case patients.24
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Patient Consent
We obtained informed consent from all Nipah 
virus case patients and contacts represented in 
our analysis or from their proxy respondents. 
We obtained assent from children, as well as 
consent from guardians for those younger than 
11 years of age. All contacts or their proxy re-
spondents provided written consent. Patient en-
rollment often included written consent but con-
sent was sometimes oral, particularly during 
early investigations. All outbreak investigation 
protocols were approved by the government of 
Bangladesh, and the contact study protocol was 
approved by the icddr,b human subjects review 
committee.
Statistical Analysis
We calculated the serial interval (i.e., the interval 
between disease onset in a case patient and dis-
ease onset in a person infected by that patient) 
for Nipah virus using the symptom-onset dates 
of epidemiologically linked transmission pairs. 
We estimated the incubation period for second-
ary cases with known exposure windows and 
symptom-onset dates.
We estimated the reproduction number (i.e., 
the average number of secondary cases per case 
patient) on the basis of identified transmission 
trees and a negative binomial distribution.25 We 
report 95% confidence intervals for all estimates 
to account for unobserved cases and to provide 
predictive intervals for future outbreaks. We used 
a negative binomial regression model to show 
associations of the reproduction number with 
the demographic and clinical characteristics of 
case patients. We categorized age, hospitalization 
delays, and illness outcomes. We estimated un-
adjusted relative infectivity as the ratio between 
reproduction numbers in a univariable analysis. 
We developed a parsimonious multivariable model 
that included variables associated in the univari-
able analysis (P≤0.05) and iteratively removed 
variables until only those with P values of 0.05 
or less were retained. We assessed whether the 
number of secondary cases was associated with 
the number of contacts per case patient. Second-
ary case patients who had multiple potential 
infectors were excluded from the risk-factor 
analysis. We tested the sensitivity of estimates to 
their inclusion, as well as to the exclusion of any 
individual case, changes in surveillance, or imple-
mentation of interventions.
We investigated factors associated with infec-
tion among contacts using a multilevel logistic-
regression model. We defined relationship to a 
case patient as a spouse, close family member 
(parent, child, or sibling), or other contact and 
categorized the duration of exposure. To test the 
transmission hypotheses, we aggregated 32 of 
38 investigated exposure types into the follow-
ing five partially overlapping groups: physical 
contact with a case patient,5,6 touching a case 
patient’s face, contact with a case patient’s respi-
ratory secretions,1,8,26 contact with an item that 
had been touched by a case patient,5 and drying 
out the case patient’s mouth and nose after 
death.4,7 All exposures linked to respiratory se-
cretions were grouped into a category that com-
prised all body-fluid exposures, which could in-
clude other body fluids, such as urine or vomitus. 
We estimated unadjusted odds ratios in univari-
able analysis and developed a multivariable model 
as described previously. We included a case-patient 
random intercept in univariable and multivari-
able models and assessed differences between 
infecting strains by including a random inter-
cept for each spillover event in the multivariable 
model and testing statistical significance by the 
likelihood ratio test. We excluded contacts’ rela-
tionship to the case patient from multivariable 
analysis because of the strong correlation with 
exposure variables. We excluded from the analy-
sis case–contact pairs in which contacts had 
potential alternative infection sources and inves-
tigated sensitivity to their inclusion. Additional 
details about the statistical analysis are provided 
in the Supplementary Appendix.
R esult s
Characteristics of the Case Patients
During the period from April 2001 through April 
2014, a total of 248 Nipah virus cases (141 con-
firmed and 107 probable) were detected in Ban-
gladesh (Table S2 in the Supplementary Appen-
dix); 3 case patients (1.2%) were health care 
workers. The median age of the patients was 24 
years (interquartile range, 10 to 35); 64% (158 
patients) were male (Table 1). Most case patients 
had respiratory symptoms, such as difficulty 
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no. of secondary  
cases/case patients
Sex
Female  90/248 (36)  5/90   0.06 (0.02–0.2) Reference
Male 158/248 (64)  74/158 0.5 (0.2–0.9) 8.4 (2.0–35) 0.006 NA
Age
≤14 yr  91/248 (37)  1/91    0.01 (0.00–0.09)   0.01 (0.00–0.1)  0.02 (0.00–0.2)
15 to 29 yr  55/248 (22) 10/55  0.2 (0.06–0.6)  0.2 (0.04–1.0) <0.001 0.3 (0.05–1.3)
30 to 44 yr  62/248 (25) 31/62 0.5 (0.2–1.3) 0.5 (0.1–2.4) 0.8 (0.2–3.4)
≥45 yr  40/248 (16) 37/40 0.9 (0.3–2.9) Reference Reference
Source of infection
Spillover or unidentified 
source¶
166/248 (67)  50/166 0.3 (0.1–0.7) Reference
Person-to-person  82/248 (33) 29/82 0.4 (0.1–1.1) 1.2 (0.3–4.5) 0.81 NA
Hospitalization after symp-
tom onset
≤2 days  36/248 (15)  2/36   0.06 (0.01–0.4) Reference
3 to 5 days 128/248 (52)  36/128 0.3 (0.1–0.6) 5.1 (0.6–44) 0.18 NA
≥6 days  58/248 (23) 15/58  0.3 (0.08–0.9) 4.7 (0.4–49) NA
Not hospitalized  26/248 (10) 26/26 1.0 (0.2–5.6) 18 (1.3–252) NA
Illness outcome‖
Survived ≤7 days 140/244 (57)  74/140 0.5 (0.1–2.1) Reference
Survived >7 days 104/244 (43)   5/104   0.05 (0.01–0.2)   0.09 (0.02–0.4) 0.001 NA
Difficulty breathing
No  91/243 (37)  2/91   0.02 (0.00–0.1) Reference Reference
Yes 152/243 (63)  77/152 0.5 (0.3–1.0) 23 (4.1–130) <0.001 19 (3.2–114)
Cough
No 118/242 (49)  25/118 0.2 (0.0– 0.5) Reference
Yes 124/242 (51)  54/124 0.4 (0.2–1.0) 2.1 (0.6–7.2) 0.27 NA
Vomiting
No 110/244 (45)  21/110  0.2 (0.07–0.5) Reference
Yes 134/244 (55)  58/134 0.4 (0.2–1.0) 2.3 (0.6–8.0) 0.22 NA
*  Included are laboratory-confirmed and probable Nipah virus cases identified in Bangladesh from April 2001 through April 2014.
†  Total number is the number of cases with available information.
‡  The reproduction number is the average number of secondary cases per case patient.
§  Relative infectivity (defined as the ratio between reproduction numbers) and 95% confidence intervals were estimated on the basis of a neg-
ative binomial regression analysis. Adjusted relative infectivity was estimated with adjustment for age and difficulty breathing. Three second-
ary cases with multiple potential infectors were excluded from the analysis (Fig. S4 in the Supplementary Appendix). The adjusted relative 
infectivity was not applicable (NA) for variables that were excluded from the multivariable model.
¶  Spillover refers to introduction of Nipah virus from the bat reservoir into the human population.
‖  A total of 78% of cases (193 of 248) were fatal; dates of death were unknown in 4 fatal cases.
Table 1. Nipah Virus Cases and Risk Factors Associated with Reproduction Number. *
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breathing (152 of 243 patients with available 
data [63%]) and cough (124 of 242 patients 
[51%]); 193 of the 248 case patients (78%) died 
(Table 1).
Contact Characteristics
Contacts were traced for 140 of the 146 case pa-
tients (96%) who were identified after protocols 
were implemented. Those 140 case patients had 
2606 contacts, representing 2494 persons; 73 of 
the individual contacts, including 3 who were 
infected with Nipah virus, had contact with mul-
tiple case patients. A total of 35 of the 2494 
persons who came in contact with a case patient 
(1.4%) probably acquired Nipah virus through 
person-to-person transmission. No asymptomatic 
infections were detected among 1863 persons 
who underwent serologic testing and had no 
signs of illness. Case patients had a median of 
17 contacts (interquartile range, 12 to 22); 51% 
of contacts (1317 of 2606) were male, and the 
median age was 32 years (interquartile range, 22 
to 44) (Table 2). Spouses represented 2.1% of 
contacts (56 of 2605), and 21% of contacts (548 
of 2605) were close family members. Spouses 
spent more time with case patients than did 
other contacts (median, 81 hours vs. 5 hours; 
P<0.001 by the Wilcoxon rank-sum test) and re-
ported types of investigated exposure more often 
than did other contacts (Table S6 in the Supple-
mentary Appendix).
Person-to-Person Transmission
Nipah virus infection in 82 of the 248 case pa-
tients was suspected to be the result of person-
to-person transmission, which corresponded to 
a reproduction number of 0.33 (95% confidence 
interval [CI], 0.19 to 0.59). We identified 17 
transmission trees; the largest extended over five 
generations and included 32 cases5 (Fig. 1A and 
1B). A single infector could be identified for 
each patient in 79 of the 82 secondary cases 
(96%). The number of secondary cases per case 
patient was highly overdispersed: 5% of case 
patients (12 of 248) were responsible for 86% of 
transmission events (68 of 79) (Fig. 1C). A total 
of 9% of case patients (22 of 248) transmitted 
Nipah virus.
Key Time Periods
The median serial interval was 13 days (inter-
quartile range, 12 to 14; mean, 13) (Fig. 1D). 
Symptoms developed within 13 days after infec-
tion in an estimated 95% of secondary cases 
(Fig. S2 in the Supplementary Appendix).
The median time from symptom onset to 
death was 6 days (interquartile range, 4 to 8). A 
total of 222 of the 248 case patients (90%) were 
hospitalized; admissions occurred within a me-
dian of 4 days (interquartile range, 3 to 6) after 
symptom onset. Among patients who died, 
death occurred within a median of 2 days (inter-
quartile range, 1 to 3) after hospitalization.
Risk Factors Associated with  
the Reproduction Number
In a univariable analysis, the reproduction num-
ber increased with age (Table 1). The reproduc-
tion number, excluding three secondary case 
patients who had multiple potential infectors, 
was highest among case patients 45 years of age 
or older (0.9; 95% CI, 0.3 to 2.9) and lowest 
among those 14 years of age or younger (0.01; 
95% CI, 0.00 to 0.09). Male case patients in-
fected, on average, 8.4 times as many persons 
(95% CI, 2.0 to 35) as female case patients, and 
case patients with difficulty breathing infected 
more contacts than those who did not have dif-
ficulty breathing (relative infectivity, 23; 95% CI, 
4.1 to 130). No survivors transmitted Nipah virus; 
case patients who survived more than 7 days 
caused fewer secondary cases than those who 
died earlier, with a relative infectivity of 0.09 
(95% CI, 0.02 to 0.4). In a multivariable analysis, 
the reproduction number was highest among 
case patients 45 years of age or older who had 
difficulty breathing (1.1; 95% CI, 0.4 to 3.2) 
(Table 1 and Fig. 2A). After adjustment for age, 
case patients who did not have difficulty breath-
ing infected, on average, 0.05 times as many 
persons (95% CI, 0.01 to 0.3) as those who had 
difficulty breathing (Fig. 2B). The multivariable 
model reasonably predicted observed reproduc-
tion numbers by age (Fig. 2C). The number of 
contacts was not associated with the number of 
secondary cases (Fig. S6 in the Supplementary 
Appendix).
Risk Factors for Infection among Contacts
We found, after excluding 6 case–contact pairs 
in which contacts had potential alternative in-
fection sources, that spouses of case patients 
were more often infected (8 of 56 [14%]) than 
close family members (7 of 547 [1.3%]) or other 
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contacts (18 of 1996 [0.9%]) (P<0.001). No male 
spouses became infected, and male contacts 
became infected less often than female contacts 
(11 of 1312 [0.8%] vs. 22 of 1288 [1.7%]; odds 
ratio, 0.4; 95% CI, 0.2 to 0.9) (Table 2).
Infected contacts spent more time with case 
patients than noninfected contacts did (median, 
24 hours vs. 5 hours; P = 0.003 by the Wilcoxon 
rank-sum test) (Fig. 3A), and the risk was high-
est among contacts who were exposed for more 
than 12 hours to 48 hours (5 of 161 contacts 
[3.1%] infected) (Fig. 3B). With inclusion of a 
random intercept for each case, the odds of in-
fection peaked among contacts who had more 
than 48 hours of exposure (odds ratio for >48 
hours vs. ≤1 hour, 22; 95% CI, 4.9 to 103).
More than 99% of contacts (2589 of 2593) 
reported physical contact with a case patient. 
The risk of infection was higher among contacts 
who were exposed to cases patients’ body fluids 
Figure 1. Person-to-Person Transmission during Nipah Virus Outbreaks in Bangladesh.
Data are from Nipah virus cases identified in Bangladesh from April 2001 through April 2014. Panel A shows 17 Nipah virus person-to-person trans-
mission trees (i.e., infection events originating from a single introduction and connected through person-to-person transmission). Squares indi-
cate primary case patients and circles patients infected by person-to-person transmission. Blue squares and circles represent patients 25 years 
of age and older with difficulty breathing, a combination of characteristics that can help to identify patients who are likely to transmit Nipah virus 
(Fig. S11 in the Supplementary Appendix). Alternative transmission scenarios for patients with two potential infectors are presented by red arrows. 
One patient (indicated by the yellow arrow) was probably infected by 1 of the 11 patients with secondary cases in the cluster, although exposure to 
other cases than the index case (who was excluded as infector) was not reported; 148 cases were not linked to any person-to-person transmission 
tree and are not represented here. Panel B shows the distribution of Nipah virus transmission trees according to the size of the tree, and Panel C 
shows the distribution of the number of secondary cases per Nipah virus case. Three secondary cases with multiple potential infectors were ex-
cluded. The inset shows a portion of the same data, beginning with the number of secondary cases among case patients who infected at least one 
other person, on an expanded y axis. Panel D shows the distribution of the serial interval (the time between symptom onset in an infector to symp-
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than among those who were not exposed (20 of 
944 [2.1%] vs. 13 of 1652 [0.8%]; odds ratio, 7.6; 
95% CI, 3.1 to 19) (Table 2).
In multivariable analysis, the duration of ex-
posure and exposure to body fluids remained 
significantly associated with infection (adjusted 
odds ratio for exposure duration >48 hours vs. 
≤1 hour, 13; 95% CI, 2.6 to 62; and adjusted 
odds ratio for exposure to body fluids, 4.3; 95% 
CI, 1.6 to 11) (Table 2 and Fig. 3C and 3D). The 
odds of infection depended on the case patient 
to whom the contact was exposed (P<0.001) and 
not on the spillover event (P = 1.00).
 Sensitivity Analysis
The reproduction number among primary cases 
was 0.30 (95% CI, 0.15 to 0.61), a finding that 
suggests that Nipah virus has lower transmis-
sion potential than required for self-sustaining 
transmission of pathogens; among cases identi-
fied since hospital-based surveillance was imple-
mented, the reproduction number was 0.23 (95% 
CI, 0.11 to 0.46) (Table S4 in the Supplementary 
Appendix). Analyses with inclusion of case pa-
tients or contacts with multiple potential infec-
tors or with exclusion of individual cases showed 
results consistent with the main analysis.
 Discussion
Using data from 14 years of outbreak investiga-
tions and 8 years of contact studies, we showed 
that Nipah virus infections among case contacts 
resulted in overt disease, with no evidence of 
asymptomatic infection, and that the risk of in-
fection was higher among persons who had 
longer contact with case patients and who were 
exposed to body fluids. We also found that the 
number of secondary infections was associated 
with the age of the patients infected with Nipah 
virus but not with the total number of contacts. 
In addition, our study is consistent with previous 
findings linking Nipah virus transmission to 
increased respiratory symptoms.1
The risk of infection was highest among 
spouses and persons who had intense and lon-
ger exposure to infected persons and were prob-
ably the principal caregivers.27 Health care work-
ers rarely acquired infection from a patient, 
probably owing to limited intensity of expo-
sure.27-29 As the health care system in Bangladesh 
develops, increasing involvement of health care 
workers in direct patient care may increase the 
risk of infection.30
Observations from our study are consistent 
Figure 2. Risk Factors Associated with the Reproduction Number.
Panel A shows the predicted reproduction number according to age intervals for Nipah virus case patients with difficulty breathing. 
 Reproduction numbers with 95% confidence intervals (indicated by the I bars) were estimated with the use of a multivariable negative 
binomial regression model that included age and difficulty breathing. Panel B shows the age-adjusted relative infectivity (i.e., the ratio 
between reproduction numbers) of case patients without difficulty breathing as compared with case patients with difficulty breathing. 
Panel C shows the observed reproduction number (empirical mean) according to age intervals and predictions based on the negative 
 binomial regression model that included age and difficulty breathing. Prediction 95% confidence intervals were obtained with the use 
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with a previously suggested role of respiratory 
secretions as a risk factor for transmission.1,9,10 
Persons infected with Nipah virus who had dif-
ficulty breathing were associated with a larger 
number of secondary cases, and contacts ex-
posed to body fluids were more likely to become 
infected than those who were not exposed to 
body fluids, data that are consistent with detec-
tion of Nipah virus RNA in respiratory and oral 
secretions.9,11 Limited evidence of person-to-
person transmission during a Nipah virus out-
break in Malaysia in which fewer respiratory 
symptoms were reported is consistent with re-
spiratory secretions playing a role in transmis-
sion.8,31,32 Despite the observed link with trans-
mission, only 61% of patients with secondary 
cases reported exposure to body fluids, a finding 
that potentially reflects misclassification of re-
called exposures or alternative transmission 
routes. In a univariable analysis, the reproduc-
Figure 3. Risk Factors Associated with Infection among Contacts of Nipah Virus Case Patients.
Data include contacts identified from January 2007 through April 2014. Panel A shows the duration of exposure 
among contacts who became infected and those who did not. In Panel A, the horizontal line represents the median, 
the top and bottom of the boxes represent the quartiles, and the I bars represent the range excluding outliers. Panel 
B shows observed percentage of contacts who became infected, according to the duration of exposure. The 95% 
confidence intervals of percentages were estimated by the Clopper–Pearson exact method. The I bars in Panels B, 
C, and D represent the 95% confidence intervals. Panel C shows the adjusted odds ratio of Nipah virus infection 
among contacts with various exposure durations as compared with contacts exposed for 1 hour or less (reference). 
Estimates were obtained on the basis of a multivariable logistic regression model that included the duration of ex-
posure and exposure to body fluids as covariates and a random intercept per case. Panel D shows the adjusted 
odds ratio of Nipah virus infection among contacts exposed to case patients’ body fluids as compared with con-
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tion number was higher among male patients 
than among female patients.
Reproduction numbers and case fatalities 
were both highest among patients in late adult-
hood (Fig. S10 in the Supplementary Appendix). 
In Bangladeshi hospitals with insufficient re-
sources for infection control, targeting older 
patients may be a useful strategy to reduce the 
risk of transmission (Fig. S11 in the Supplemen-
tary Appendix). Unmeasured covariates, such as 
viral load, could be associated with viral shed-
ding and disease severity and could change as a 
function of age, as observed with Ebola virus.33,34 
Quantifying viral loads among patients infected 
with Nipah virus may help to better characterize 
the transmission risk, although current data on 
viral loads are limited (Fig. S12 in the Supple-
mentary Appendix).
Our study provides evidence that asymptom-
atic and mild Nipah virus infections are rare. 
Thus, estimates of the reproduction number and 
risk factors of infection and transmission prob-
ably can focus on symptomatic cases.
This study had a number of limitations. First, 
exposure to body fluids included respiratory se-
cretions but potentially also included other fluid 
types. Future investigations should collect spe-
cific information on exposure to respiratory se-
cretions. Second, health care workers were not 
included in contact tracing until 2012; however, 
only a few Nipah virus transmissions were iden-
tified in this population. Third, although un-
usual events outside the assumed windows of 
incubation and infectivity periods may have 
occurred, these appear to be rare (Fig. S3 in the 
Supplementary Appendix) and are unlikely to 
have influenced our findings. Fourth, in the 
cases of deceased or severely ill persons, inter-
views were conducted with close relatives, which 
may have led to misclassifications of the types 
of exposure. Fifth, isolated cases or small case 
clusters may have gone undetected, particularly 
before the implementation of hospital-based 
surveillance, which may have resulted in over-
estimation of the reproduction number. This, 
however, would not affect the conclusion that 
the transmission potential is currently lower 
than required for self-sustaining transmission 
and is unlikely to influence risk-factor estimates. 
Sixth, diversity in virus strains may have contrib-
uted to variations in infectivity; however, investi-
gating these effects is currently not possible, since 
only few Nipah virus strains were sequenced9,11 
(see the Supplementary Appendix), and repre-
sents a key future research area. Finally, we 
characterized Nipah virus transmission only in 
Bangladesh and therefore cannot assess trans-
mission dynamics elsewhere. Bangladesh is the 
only country reporting Nipah virus outbreaks 
regularly, with 79 reported spillover events from 
April 2001 through April 2014, and our study 
includes all but three known outbreaks of Nipah 
virus with person-to-person transmission.23,30,35
This study highlights patient characteristics 
and contact behaviors that may be related to 
Nipah virus person-to-person transmission. In-
terventions should aim to reduce exposure to 
body fluids, particularly oral secretions, and tar-
get prevention strategies for persons who have 
sustained contact with infected patients.
The findings and conclusions in this report are those of the 
authors and do not necessarily represent the official position of 
the Centers for Disease Control and Prevention (CDC).
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